Latest Los Alamos National Laboratory Stories

Los Alamos National Laboratory The new material has the highest oxygen reduction reaction (ORR) activity in alkaline media of any non-precious metal catalyst developed to date. Los Alamos National Laboratory scientists have designed a new type of nanostructured-carbon-based catalyst that could pave the way for reliable, economical next-generation batteries and alkaline fuel cells, providing for practical use of wind- and solar-powered electricity, as well as enhanced hybrid electric...

Knowledge Foundation and Oak Ridge National Laboratory brings the 2nd Biosurveillance Symposium and Biodetection Technologies 2013 to Alexandria, VA on June 17 - 19, 2013. Boston, MA (PRWEB) May 22, 2013 Industry leaders from around the world will convene in Alexandria, VA for the Oak Ridge National Laboratory’s Biosurveillance Symposium on June 17th which will take place at the Hilton Alexandria Mark Center. Held in conjunction will be the Biodetection Technologies 2013 conference on...

Securing the grid will be key for energy security going forward NATIONAL HARBOR, Md., May 21, 2013 /PRNewswire-USNewswire/ -- Los Alamos National Laboratory Director Charlie McMillan told a gathering of energy executives today that securing the electrical grid is a major concern now and it's only becoming more serious. (Photo: http://photos.prnewswire.com/prnh/20130521/DC18652) "If you look back at the last year, there were several hundred attacks on critical infrastructure,"...

Researchers produce molybdenum-99 from irradiation of low-enriched uranium solution LOS ALAMOS, N.M., May 13, 2013 /PRNewswire-USNewswire/ -- Today, Los Alamos National Laboratory announced that for the first time, irradiated uranium fuel has been recycled and reused for molybdenum-99 (Mo-99) production, with virtually no losses in Mo-99 yields or uranium recovery. This demonstrates the viability of the separation process, as well as the potential for environmentally- and...

LOS ALAMOS, N.M., April 29, 2013 /PRNewswire/ -- / Continental Who's Who/- David R. Janecky, Ph.D. is recognized by Continental Who's Who as a Pinnacle Professional among Scientific Researchers. David is a Group Leader with Los Alamos National Laboratory. In his current role, David specializes in Geosciences as well as Technical Management. In addition, David has served on numerous advisory boards and review committees as well as being a Post Doctoral Scholar sponsor at LANL and a...

These findings will help inform vaccine design and interpretation of vaccine trials, and provide new insights into the basic biology of viral/host dynamics of infection. A new study by Los Alamos National Laboratory and University of Pennsylvania scientists defines previously unknown properties of transmitted HIV-1, the virus that causes AIDS. The viruses that successfully pass from a chronically infected person to a new individual are both remarkably resistant to a powerful initial human...

Los Alamos National Laboratory Members of the Mars Science Laboratory Curiosity rover ChemCam team will present more than two dozen posters and talks next week during the 44th Lunar and Planetary Science Conference in The Woodlands, Texas. “ChemCam has performed flawlessly in its first six months, providing more than a gigabyte of exciting new information about the Red Planet,” said Los Alamos National Laboratory planetary scientist Roger Wiens, Principal Investigator of the ChemCam...

A study reveals how daclatasvir targets one of its proteins and causes the fastest viral decline ever seen with anti-HCV drugs – within 12 hours of treatment. A study by researchers from Los Alamos National Laboratory and a multinational team reveals how daclatasvir, a direct-acting antiviral agent in development for the treatment of hepatitis C virus (HCV), targets one of its proteins and causes the fastest viral decline ever seen with anti-HCV drugs – within 12 hours of treatment....

LOS ALAMOS, N.M., Feb. 19, 2013 /PRNewswire-USNewswire/ -- A study by researchers from Los Alamos National Laboratory and a multinational team reveals how daclatasvir, a direct-acting antiviral agent in development for the treatment of hepatitis C virus (HCV), targets one of its proteins and causes the fastest viral decline ever seen with anti-HCV drugs - within 12 hours of treatment. Chronic infection with hepatitis C virus affects about 150 million people worldwide. It is the...

LOS ALAMOS, N.M., Feb. 14, 2013 /PRNewswire-USNewswire/ -- Recently a Los Alamos National Laboratory quantum cryptography (QC) team successfully completed the first-ever demonstration of securing control data for electric grids using quantum cryptography. (Photo: http://photos.prnewswire.com/prnh/20130214/DC60813) The demonstration was performed in the electric grid test bed that is part of the Trustworthy Cyber Infrastructure for the Power Grid (TCIPG) project at the University...